Abstract
Of all sexually active couples, 12–15% are infertile. When broken down by gender, a male component can be identified 50% of the time either in isolation or in combination with a female factor. The majority of the causes of male infertility are treatable or preventable, so a keen understanding of these conditions is paramount. Despite advancements in assisted reproductive technologies, the goal of a male infertility specialist is not simply to retrieve sperm. Instead, the male infertility specialist attempts to optimize a male’s reproductive potential and thereby allow a couple to conceive successfully through utilization of less invasive reproductive techniques. Often, this involves the use of sperm or testicular tissue cryopreservation prior to fertility insult. At the same time, the male fertility specialist is wary of underlying or causal, potentially serious medical or genetic conditions that prompted reproductive evaluation. Previous research in a US male fertility clinic analyzing 1,430 patients identified causes of infertility from most to least common: varicocele, idiopathic, obstruction, female factor, cryptorchidism, immunologic, ejaculatory dysfunction, testicular failure, drug effects/radiation, endocrinology, and all others. The focus of this book on the role of reactive oxygen species (ROS) is easily applied to the majority of the listed conditions (described in detail in later chapters) which comprise this chapter’s overview of pre-testicular, testicular, and post-testicular causes of male infertility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Mosher WE. Reproductive impairments in the United States, 1965–1982. Demography. 1985;22:415–30.
Tielemans E, Burdorf A, te Velde E, Weber R, van Kooij R, Heederik D. Sources of bias in studies among infertility clients. Am J Epidemiol. 2002;156:86–92.
Sigman M. Male Infertility. Med Health R I. 1997;80(12):406–9.
Buvat J. Hyperprolactinemia and sexual function in men: a short review. Int J Impot Res. 2003;15(5):373–7.
Carter JN, Tyson JE, Tolis G, et al. Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med. 1978;299(16):847–52.
Patel SS, Bamigboye V. Hyperprolactinaemia. J Obstet Gynaecol. 2007;27(5):455–9.
Fasano S, Meccariello R, Cobellis G, et al. The endocannabinoid system: an ancient signaling involved in the control of male fertility. Ann N Y Acad Sci. 2009;1163:112–24.
Rettori V, De Laurentiis A, Fernandez-Solari J. Alcohol and endocannabinoids: neuroendocrine interactions in the reproductive axis. Exp Neurol. 2010;224(1):15–22.
Hallinan R, Byrne A, Agho K, et al. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl. 2009;32(2):131–9.
Dodé C, Hardelin JP. Kallmann syndrome. Eur J Hum Genet. 2009;17:139–46.
Fechner A, Fong S, McGovern P. A review of Kallmann syndrome: genetics, pathophysiology, and clinical management. Obstet Gynecol Surv. 2008;63(3):189–94.
Hardelin JP, Dode C. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev. 2008;2:181–93.
Kamischke A, Baumgardt A, Horst J, et al. Clinical and diagnostic features of patients with suspected Klinefelter Syndrome. J Androl. 2003;24:41–8.
Blanco J, Egozcue J, Vidal F. Meiotic behavior of the sex chromosomes in three patients with sex chromosome abnormalities (47, XXY, mosaic 46, XY/47, XXY, and 47, XYY) assessed by flourescence in-situ hybridization. Hum Reprod. 2001;16(5):887–92.
Bergere M, Wainer R, Nataf V, et al. Biopsied testis cells of four 47, XXY patients: fluorescence in-situ hybridization and ICSI results. Hum Reprod. 2002;17:32–7.
Wikström AM, Dunkel L. Testicular function in Klinefelter syndrome. Horm Res. 2008;69(6):317–26.
Nagler HM, Grotas AB. Varicocele. In: Lipshultz LI, Howards SS, Niederberger CS, editors. Infertility in the male. 4th ed. New York City, NY: Cambridge University; 2009.
World Health Organization. The influence of varicocele on parameters of fertility in a large group of men presenting to infertility clinics. Fertil Steril. 1992;57:1289–93.
MacLeod J. Seminal cytology in the presence of varicocele. Fertil Steril. 1965;16(6):735–57.
Paduch DA, Niedzielski J. Semen analysis in young men with varicocele: preliminary study. J Urol. 1996;156:778–90.
Hjollund NH, Storgaard L, Ernst E, et al. The relation between daily activities and scrotal temperature. Reprod Toxicol. 2002;16(3):209–14.
Ivell R. Lifestyle impact and the biology of the human scrotum. Reprod Biol Endocrinol. 2007;5:15.
Paul C, Murray AA, Spears N, et al. A single, mild, transient scrotal heat stress causes DNA damage, subfertility and impairs formation of blastocysts in mice. Reproduction. 2008;136(1):73–84.
Dada R, Gupta NP, Kucheria K. Spermatogenic arrest in men with testicular hyperthermia. Teratog Carcinog Mutagen. 2003;S1:235–43.
Esfandiari N, Saleh RA, Blaut AP, et al. Effects of temperature on sperm motion characteristics and reactive oxygen species. Int J Fertil Womens Med. 2002;47(5):227–33.
Bedford JM. Effects of elevated temperature on the epididymis and testis: experimental studies. Adv Exp Med Biol. 1991;286:19–32.
Hjollund NH, Bonde JP, Jensen TK, et al. Diurnal scrotal skin temperature and semen quality. The Danish first pregnancy planner study team. Int J Androl. 2000;23(5):309–18.
Wang C, McDonald V, Leung A, et al. Effect of increased scrotal temperature on sperm production in normal men. Fertil Steril. 1997;68(2):334–9.
Zorgniotti AW, MacLeod J. Studies in temperature, human semen quality, and varicocele. Fertil Steril. 1973;24(11):854–63.
Jung A, Eberl M, Schill WB. Improvement of semen quality by nocturnal scrotal cooling and moderate behavioral change to reduce genital heat stress in men with oligoasthenoteratozoospermia. Reproduction. 2001;121(4):595–603.
Goldstein M, Eid JF. Elevation of intratesticular and scrotal skin surface temperature in men with varicocele. J Urol. 1989;142(3):743–5.
Trsinar B, Muravec UR. Fertility potential after unilateral and bilateral orchidopexy for cryptorchidism. World J Urol. 2009;27(4):513–9.
Gracia J, Sánchez Zalabardo J, Sánchez García J, et al. Clinical, physical, sperm and hormonal data in 251 adults operated on for cryptorchidism in childhood. BJU Int. 2000;85(9):1100–3.
Lee PA, O’Leary LA, Songer NJ, et al. Paternity after unilateral cryptorchidism: a controlled study. Pediatrics. 1996;98:676–9.
Lee PA, O’Leary LA, Songer NJ, et al. Paternity after bilateral cryptorchidism. A controlled study. Arch Pediatr Adolesc Med. 1997;151(3):260–3.
Canavese F, Mussa A, Manenti M, et al. Sperm count of young men surgically treated for cryptorchidism in the first and second year of life: fertility is better in children treated at a younger age. Eur J Pediatr Surg. 2009;19(6):388–91.
Wiser A, Raviv G, Weissenberg R, et al. Does age at orchidopexy impact on the results of testicular sperm extraction? Reprod Biomed Online. 2009;19(6):778–83.
Cooper ER. The histology of the retained testis in the human subject at different ages and its comparison to the testis. J Anat. 1929;64:5–10.
Murphy F, Paran TS, Puri P. Orchidopexy and its impact on fertility. Pediatr Surg Int. 2007;23(7):625032. Epub 13 Mar 2007.
Setchell BP. The Parkes Lecture: heat and the testis. J Reprod Fertil. 1998;114(2):179–94.
Leissner J, Filipas D, Wolf HK, et al. The undescended testis: considerations and impact on fertility. BJU Int. 1999;83(8):885–91.
Hadziselimovic F, Zivkovic D, Bica DTG, et al. The importance of mini-puberty for fertility in cryptorchidism. J Urol. 2005;174:1536–9.
Kurpisz M, Havryluk A, Nakonechnyj A, et al. Cryptorchidism and long-term consequences. Reprod Biol. 2010;10(1):19–35.
Jørgensen N, Meyts ER, Main KM, Skakkebaek NE. Testicular dysgenesis syndrome comprises some but not all cases of hypospadias and impaired spermatogenesis. Int J Androl. 2010;33(2):298–303. Epub 4 Feb 2010.
Abe T, Takaha N, Tsujimura A, et al. Leydig cell tumor of the testis presenting male infertility: a case report. Hinyokika Kiyo. 2003;49(1):39–42.
Shiraishi Y, Nishiyama H, Okubo K, et al. Testicular Leydig cell tumor presenting as male infertility: a case report. Hinyokika Kiyo. 2009;55(12):777–81.
Chovelidze S, Kochiashvili D, Gogeschvili G, et al. Cases of Leydig cell tumor in male infertility. Georgian Med News. 2007;143:76–9.
Hayashi T, Arai G, Hyochi N, et al. Suppression of spermatogenesis in ipsilateral and contralateral testicular tissues in patients with seminoma by human chorionic gonadotropin beta subunit. Urology. 2001;58(2):251–7.
Ho GT, Gardner H, DeWolf WC, et al. Influence of testicular carcinoma on ipsilateral spermatogenesis. J Urol. 1992;148(3):821–5.
Carmignani L, Gadda F, Paffoni A, et al. Azoospermia and severe oligospermia in testicular cancer. Arch Ital Urol Androl. 2009;81(1):21–3.
Rowley MJ, Leach DR, Warner GA, et al. Effect of graded doses of ionizing radiation on the human testis. Radiat Res. 1974;59(3):665–78.
Paulsen CA. The study of radiation effects on the human testis: including histologic, chromosomal and hormonal aspects. Final progress report of AEC contract AT(45-1)-2225, Task Agreement 6. RLO-2225-2. 1973.
Speiser B, Rubin P, Casarett G. Aspermia following lower truncal irradiation in Hodgkin’s disease. Cancer. 1973;32(3):692–8.
Ash P. The influence of radiation on fertility in man. Br J Radiol. 1980;53:271–8.
Giwercman A, von der Maase H, Berthelsen JG, et al. Localized irradiation of testes with carcinoma in situ: effects of Leydig cell function and eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab. 1991;73(3):596–603.
Shapiro E, Kinsella TJ, Makuch RW, et al. Effects of fractionated irradiation on endocrine aspects of testicular function. J Clin Oncol. 1985;3(9):1232–9.
Spitz S. The histological effects of nitrogen mustard on human tumours and tissues. Cancer. 1948;1(3):383–98.
Watson AR, Rance CP, Bain J. Long term effects of cyclophosphamide on testicular function. BMJ. 1985;291:1457–60.
Pryzant RM, Meistrich ML, Wilson G, et al. Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin’s lymphomas. J Clin Oncol. 1993;11(2):239–47.
da Cunha MF, Meistrich ML, Fuller LM, et al. Recovery of spermatogenesis after treatment for Hodgkin’s disease: limiting dose of MOPP chemotherapy. J Clin Oncol. 1984;2(6):571–7.
Meistrich ML, Chawla SP, Da Cunha MF, et al. Recovery of sperm production after chemotherapy for osteosarcoma. Cancer. 1989;63(11):2115–23.
Pectasides D, Pectasides M, Farmakis D. Testicular function in patients with testicular cancer treated with Bleomycin-Etoposide-Carboplatin (BEC90) combination chemotherapy. Eur Urol. 2004;45(2):187–93.
Pont J, Albrect W. Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril. 1997;68:1–5.
Ishikawa T, Kamidono S, Fujisawa M. Fertility after high-dose chemotherapy for testicular cancer. Urology. 2004;63:137–40.
Sakamoto H, Oohta M, Inoue K, et al. Testicular sperm extraction in patients with persistent azoospermia after chemotherapy for testicular germ cell tumor. Int J Urol. 2007;14(2):167–70.
Ferlin A, Raicu F, Gatta V, Zuccarello D, Palka G, Foresta C. Male infertility: role of genetic background. Reprod Biomed Online. 2007;14(6):734–45.
Foresta C, Moro E, Ferlin A. Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev. 2001;22(2):226–39.
Vogt PH. Azoospermia factor (AZF) in Yq11: towards a molecular understanding of its function for human male fertility and spermatogenesis. Reprod Biomed Online. 2005;10(1):81–93.
Stahl PJ, Masson P, Mielnik A, et al. A decade of experience emphasizes that testing for Y microdeletions is essential in American men with azoospermia and severe oligozoospermia. Fertil Steril. 2010;94(5):1753–6.
Bojesen A, Gravholt CH. Klinefelter syndrome in clinical practice. Nat Clin Pract Urol. 2007;4(4):192–204.
Ferlin A, Garolla A, Foresta C. Chromosome abnormalities in sperm of individuals with constitutional sex chromosomal abnormalities. Cytogenet Genome Res. 2005;111:310–6.
Zhou-Cun A, Yang Y, Zhang SZ, et al. Chromosomal abnormality and Y chromosome microdeletion in Chinese patients with azoospermia or severe oligozoospermia. Yi Chuan Xue Bao. 2006;33(2):111–6.
Foresta C, Garolla A, Bartoloni L, Bettella A, Ferlin A. Genetic abnormalities among severely oligospermic men who are candidates for intracytoplasmic sperm injection. J Clin Endocrinol Metab. 2005;90(1):152–6.
Schiff JD, Palermo GD, Veeck LL, et al. Intracytoplasmic sperm injection in men with Klinefelter syndrome. J Clin Endocrinol Metab. 2005;90(11):6263–7.
O’FlynnO’Brien KL, Varghese AC, Agarwal A. The genetic causes of male factor infertility: a review. Fertil Steril. 2010;93(1):1–12.
Shafik A. Contraceptive efficacy of polyester-induced azoospermia in normal men. Contraception. 1992;45(5):439–51.
Munkelwitz R, Gilbert BR. Are boxer shorts really better? A critical analysis of the role of underwear type in male subfertility. J Urol. 1998;160(4):1329–33.
Bonde JP. Semen quality in welders exposed to radiant heat. Br J Ind Med. 1992;49(1):5–10.
Jung A, Schuppe HC. Influence of genital heat stress on semen quality in humans. Andrologia. 2007;39:203–15.
Agarwal A, Deepinder F, Sharma RK, et al. Effect of cell phone usage on semen analysis in men attending infertility clinic: an observational study. Fertil Steril. 2008;89:124–8.
Agarwal A, Desai NR, Makker K, et al. Effects of radiofrequency electromagnetic waves (RF-EMW) from cellular phones on human ejaculated semen: an in vitro pilot study. Fertil Steril. 2009;92:1318–25.
Collodel G, Capitani S, Pammolli A, et al. Semen quality of male idiopathic infertile smokers and nonsmokers: an ultrastructural study. J Androl. 2010;31:108–13.
Calogero A, Polosa R, Perdichizzi A, et al. Cigarette smoke extract immobilizes human spermatozoa and induces sperm apoptosis. Reprod Biomed Online. 2009;19:564–71.
Gaur DS, Talekar MS, Pathak VP. Alcohol intake and cigarette smoking: impact of two major lifestyle factors on male fertility. Indian J Pathol Microbiol. 2010;53:35–40.
Künzle R, Mueller MD, Hänggi W, et al. Semen quality of male smokers and nonsmokers in infertile couples. Fertil Steril. 2003;79:287–91.
Brandes SB, Buckman RF, Chelsky MJ, et al. External genitalia gunshot wounds: a ten-year experience with fifty-six cases. J Trauma. 1995;39:266–71.
Cass AS, Ferrara L, Wolpert J, et al. Bilateral testicular injury from external trauma. J Urol. 1988;140:1435–6.
Kuhlmann J, Bohme H, Tauber R. Bilateral testicular gunshot injuries. Urologe A. 2005;44:918–20.
Tomomasa H, Oshio S, Amemiya H, et al. Testicular injury: late results of semen analyses after uniorchiectomy. Arch Androl. 1992;29:59–63.
Lin WW, Kim ED, Quesada ET, et al. Unilateral testicular injury from external trauma: evaluation of semen quality and endocrine parameters. J Urol. 1998;159:841–3.
Kukadia AN, Ercole CJ, Gleich P, et al. Testicular trauma: potential impact on reproductive function. J Urol. 1996;156:1643–6.
Philip J, Selvan D, Desmond A. Mumps orchitis in the non-immune postpubertal male: a resurgent threat to male fertility? BJU Int. 2006;97:138–41.
Masarani M, Wazait H, Dinneen M. Mumps orchitis. J R Soc Med. 2006;99:573–5.
Osegbe DN. Testicular function after unilateral bacterial epididymo-orchitis. Eur Urol. 1991;19:204–8.
Schuppe HC, Meinhardt A, Allam JP, et al. Chronic orchitis: a neglected cause of male infertility? Andrologia. 2008;40:84–91.
Zariwala MA, Knowles MR, Omran H. Genetic defects in ciliary structure and function. Annu Rev Physiol. 2007;69:423–50.
Leigh MW, Pittman JE, Carson JL, et al. Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome. Genet Med. 2009;11:473–87.
Terada T, Hatakeyama S. Morphological evidence for two types of idiopathic “Sertoli-cell-only” syndrome. Int J Androl. 1991;14(2):117–26.
Weller O, Yogev L, Yavetz H, et al. Differentiating between primary and secondary Sertoli-cell-only syndrome by histologic and hormonal parameters. Fertil Steril. 2005;83(6):1856–8.
Collins JA, Burrows EA, Yeo J, et al. Frequency and predictive value of antisperm antibodies among infertile couples. Hum Reprod. 1993;8(4):592–8.
Menge AC, Medley NE, Mangione CM, et al. The incidence and influence of antisperm antibodies in infertile human couples on sperm-cervical mucus interactions and subsequent fertility. Fertil Steril. 1982;38:439–46.
Sinisi AA, Di Finizio B, Pasquali D, et al. Prevalence of antisperm antibodies by SpermMARtest in subjects undergoing a routine sperm analysis for infertility. Int J Androl. 1993;16:311–4.
Heidenreich A, Bonfig R, Wilbert DM, et al. Risk factors for antisperm antibodies in infertile men. Am J Reprod Immunol. 1994;31:69–76.
Walsh T, Turek P. Immunologic infertility. In: Lipshultz LI, Howards SS, Niederberger CS, editors. Infertility in the male. 4th ed. New York City, NY: Cambridge University; 2009.
Meinertz H, Linnet L, Fogh-Andersen P, et al. Antisperm antibodies and fertility after vasovasostomy: a follow-up study of 216 men. Fertil Steril. 1990;54:315–21.
Hammiche F, Laven J, Boxmeer J, et al. Semen quality decline among men below 60 years of age undergoing IVF or ICSI treatment. J Androl. 2010;32:70–6. Epub ahead of print.
Belloc S, Benkhalifa M, Junca AM, et al. Paternal age and sperm DNA decay: discrepancy between chromomycin and aniline blue staining. Reprod Biomed Online. 2009;19:264–9.
Escobar MA, Grosfeld JL, Burdick JJ, et al. Surgical considerations in cystic fibrosis: a 32-year evaluation of outcomes. Surgery. 2005;138:560–71.
Wilschanski M, Corey M, Durie P, et al. Diversity of reproductive tract abnormalities in men with cystic fibrosis. JAMA. 1996;276:607–8.
Lissens W, Mercier B, Tournaye H, et al. Cystic fibrosis and infertility caused by congenital bilateral absence of the vas deferens and related clinical entities. Hum Reprod. 1996;S4:55–78.
Donat R, McNeill AS, Fitzpatrick DR, et al. The incidence of cystic fibrosis gene mutations in patients with congenital bilateral absence of the vas deferens in Scotland. Br J Urol. 1997;79:74–7.
Sokol RZ. Infertility in men with cystic fibrosis. Curr Opin Pulm Med. 2001;7:421–6.
Dörk T, Dworniczak B, Aulehla-Scholz C, et al. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet. 1997;100:365–77.
Gaillard DA, Carré-Pigeon F, Lallemand A. Normal vas deferens in fetuses with cystic fibrosis. J Urol. 1997;158:1549–52.
Radpour R, Gourabi H, Gilani M, et al. Correlation between CFTR gene mutations in Iranian men with congenital absence of the vas deferens and anatomical genital phenotype. J Androl. 2008;29:35–40.
Donohue RE, Fauver HE. Unilateral absence of the vas deferens. A useful clinical sign. JAMA. 1989;261:1180–2.
Shapiro E, Goldfarb DA, Ritchey ML. The congenital and acquired solitary kidney. Rev Urol. 2003;5:2–8.
Handelsman DJ, Conway AJ, Boylan LM, et al. Young’s syndrome. Obstructive azoospermia and chronic sinopulmonary infections. N Engl J Med. 1984;310:3–9.
Domingo C, Mirapeix RM, Encabo B, et al. Clinical features and ultrastructure of primary ciliary dyskinesia and Young syndrome. Rev Clin Esp. 1997;197:100–3.
Goeminne PC, Dupont LJ. The sinusitis-infertility syndrome: Young’s saint, old devil. Eur Respir J. 2010;35:698.
Arya AK, Beer HL, Benton J, et al. Does Young’s syndrome exist? J Laryngol Otol. 2009;123:477–81.
Smith JF, Walsh TJ, Turek PJ. Ejaculatory duct obstruction. Urol Clin North Am. 2008;35:221–7.
Paick JS, Kim SH, Kim SW. Ejaculatory duct obstruction in infertile men. BJU Int. 2000;85:720–4.
Carson CC. Transurethral resection for ejaculatory duct stenosis and oligospermia. Fertil Steril. 1984;41:482–4.
Wieder JA, Lynne CM, Ferrell SM, et al. Brown-colored semen in men with spinal cord injury. J Androl. 1999;20:594–600.
Labrecque M, Nazerali H, Mondor M, et al. Effectiveness and complications associated with 2 vasectomy occlusion techniques. J Urol. 2002;168:2495–8.
Freund MJ, Weidmann JE, Goldstein M, et al. Microrecanalization after vasectomy in man. J Androl. 1989;10:120–32.
Cruickshank B, Eidus L, Barkin M. Regeneration of vas deferens after vasectomy. Urology. 1987;30:137–42.
Hallan RI, May AR. Vasectomy: how much is enough? Br J Urol. 1988;62:377–9.
Adams CE, Wald M. Risks and complications of vasectomy. Urol Clin North Am. 2009;36:331–6.
Sokal DC, Labrecque M. Effectiveness of vasectomy techniques. Urol Clin North Am. 2009;36:317–29.
Cook LA, Van Vliet H, Lopez LM, et al. Vasectomy occlusion techniques for male sterilization. Cochrane Database Syst Rev. 2007;2:CD003991.
Jee SH, Hong YK. One-layer vasovasostomy: microsurgical versus loupe-assisted. Fertil Steril. 2010;94(6):2308–11. Epub 13 Jan 2010.
Belker AM, Thomas Jr AJ, Fuchs EF, et al. Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group. J Urol. 1991;145:505–11.
Nagler HM, Jung H. Factors predicting successful microsurgical vasectomy reversal. Urol Clin North Am. 2009;36:383–90.
Magheli A, Rais-Bahrami S, Kempkensteffen C, et al. Impact of obstructive interval and sperm granuloma on patency and pregnancy after vasectomy reversal. Int J Androl. 2010;41(1):52–7.
Witt MA, Heron S, Lipshultz LI. The post-vasectomy length of the testicular vasal remnant: a predictor of surgical outcome in microscopic vasectomy reversal. J Urol. 1994;151:892–4.
Hollingsworth MR, Sandlow JI, Schrepferman CG, et al. Repeat vasectomy reversal yields high success rates. Fertil Steril. 2007;88:217–9.
Talbot HS. The sexual function in paraplegia. J Urol. 1955;73:91–100.
Utida C, Truzzi JC, Bruschini H, et al. Male infertility in spinal cord trauma. Int Braz J Urol. 2005;31:375–83.
Narayan P, Lange PH, Fraley EE. Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer. J Urol. 1982;127:685–8.
Lange PH, Narayan P, Vogelzang NJ, et al. Return of fertility after treatment for nonseminomatous testicular cancer: changing concepts. J Urol. 1983;129:1131–5.
Pizzocaro G, Salvioni R, Zanoni F. Unilateral lymphadenectomy in intraoperative stage I nonseminomatous germinal testis cancer. J Urol. 1985;134:485–9.
Richie JP. Clinical stage 1 testicular cancer: the role of modified retroperitoneal lymphadenectomy. J Urol. 1990;144:1160–3.
Donohue JP, Foster RS, Rowland RG, et al. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol. 1990;144:287–91.
Heidenreich A, Albers P, Hartmann M, et al. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol. 2003;169:1710–4.
Pettus JA, Carver BS, Masterson T, et al. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology. 2009;73:328–31.
Hellstrom WJ, Sikka SC. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol. 2006;176:1529–33.
Marks LS, Gittelman MC, Hill LA, et al. Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. J Urol. 2009;181:2634–40.
Hisasue S, Furuya R, Itoh N, et al. Ejaculatory disorder caused by α-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission. Int J Urol. 2006;13:1311–6.
Kobayashi K, Masumori N, Hisasue S, et al. Inhibition of seminal emission is the main cause of an ejaculation induced by a new highly selective α1A-blocker in normal volunteers. J Sex Med. 2008;5:2185–90.
Smith SM, O’Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry. 2002;181:49–55.
Loh C, Leckband SG, Meyer JM, et al. Risperidone-induced retrograde ejaculation: case report and review of the literature. Int Clin Psychopharmacol. 2004;19:111–2.
Haefliger T, Bonsack C. Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone. Encéphale. 2006;32:97–105.
Agarwal A, Deepinder F, Cocuzza M, et al. Effect of vaginal lubricants on sperm motility and chromatin integrity: a prospective comparative study. Fertil Steril. 2008;89:375–9.
Kutteh WH, Chao CH, Ritter JO, et al. Vaginal lubricants for the infertile couple: effect on sperm activity. Int J Fertil Menopausal Stud. 1996;41:400–4.
Anderson L, Lewis SE, McClure N. The effects of coital lubricants on sperm motility in vitro. Hum Reprod. 1998;13:3351–6.
Nangia AK, Likosky DS, Wang D. Distribution of male infertility specialists in relation to the male population and assisted reproductive technology centers in the United States. Fertil Steril. 2010;94(2):599–609.
Further Reading
Blau H, Freud E, Mussaffi H, et al. Urogenital abnormalities in male children with cystic fibrosis. Arch Dis Child. 2002;87:135–8.
Chen-Mok M, Bangdiwala SI, Dominik R, et al. Termination of a randomized controlled trial of two vasectomy techniques. Control Clin Trials. 2003;24:78–84.
Fejes I, Závaczki Z, Koloszár S, et al. Hypothesis: safety of using mobile phones on male fertility. Arch Androl. 2007;53:105–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Wiser, H.J., Sandlow, J., Köhler, T.S. (2012). Causes of Male Infertility. In: Parekattil, S., Agarwal, A. (eds) Male Infertility. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3335-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3335-4_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3334-7
Online ISBN: 978-1-4614-3335-4
eBook Packages: MedicineMedicine (R0)